Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?

Subjects

Subjects :

Oncology
medicine.medical_specialty
biology
Surrogate endpoint
business.industry
MEDLINE
Cancer
Hematology
medicine.disease
B7-H1 Antigen
Clinical trial
Immune system
Neoplasms
Internal medicine
Programmed cell death 1
medicine
biology.protein
Humans
Immunotherapy
business

Details

ISSN :

09237534

Volume :

32

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi.dedup.....7af2d59ff08b70254c9937d2245552c4

Full Text :

https://doi.org/10.1016/j.annonc.2021.04.006